Filana Therapeutics
FLNA
101 hedge funds and large institutions have $23.1M invested in Filana Therapeutics in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 37 reducing their positions, and 19 closing their positions.
38% more call options, than puts
Call options by funds: $1.17M | Put options by funds: $849K
0.3% less ownership
Funds ownership: 28.55% → 28.25% (-0.3%)
6% less funds holding
Funds holding: 107 → 101 (-6)
16% less capital invested
Capital invested by funds: $27.3M → $23.1M (-$4.25M)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
54% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$2.77M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$927K |
| 3 |
Renaissance Technologies
New York
|
+$673K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$206K |
| 5 |
D.E. Shaw & Co
New York
|
+$185K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$593K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$536K |
| 3 |
Millennium Management
New York
|
-$415K |
| 4 |
SPS
Susquehanna Portfolio Strategies
Bala Cynwyd,
Pennsylvania
|
-$218K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$213K |
FLNA Hedge Fund Activity: Q1 2026 in Review
101 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2026, worth a combined $23.1M — down 16% from $27.3M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of FLNA and 15 opened new positions — a net loss of 4 holders — while 37 trimmed existing stakes and 17 added.
The largest buyer was Two Sigma Investments, adding an estimated $2.77M. The largest seller was Jane Street, cutting an estimated $593K.
- 101 institutional investors held Filana Therapeutics (FLNA) as of Q1 2026, down from 107 in Q4 2025.
- Funds reported $23.1M of Filana Therapeutics stock for Q1 2026, down 16% quarter-over-quarter.
- 15 funds opened new Filana Therapeutics positions in Q1 2026 and 19 closed out, a net change of -4 holders.
- The largest Filana Therapeutics buyer in Q1 2026 was Two Sigma Investments, an estimated $2.77M added.
- The largest Filana Therapeutics seller in Q1 2026 was Jane Street, an estimated $593K sold.
Based on aggregated 13F filings for Q1 2026.